Abstract:Globally, about 71 million people have chronic HCV infection. A significant number of those who are chronically infected will develop cirrhosis or liver cancer. Approximately 399, 000 person die every year from liver cirrhosis and hepatocellular carcinoma. Liver fibrosis reflects sustained liver injury often from multiple, simultaneous factors. Assessment of the effect of antiviral treatment on liver fibrosis is desirable end point for evaluation of the efficacy of therapy. To validate and compare the diagnostic performance of RDW to Platelet ratio for prediction of liver fibrosis before and after antiviral treatment in patient with chronic HCV infection. In Comparison with other markers of fibrosis (fib-4, APRI) scores and fibroscan. This study was conducted on 50 adult patients with chronic hepatitis C virus subdivided into two groups. First group: 25 Non cirrhotic patients having chronic HCV infection. Second group: 25 Cirrhotic CHILD A patients having chronic HCV infection and followed up in Gastroenterology out patient’s clinic, Al Demerdash Hospital, Ain Shams University. The results obtained can be summarized as follows: RDW/PLT can predict liver fibrosis and cirrhosis with agood degree of accuracy before HCV treatment. RDW/PLT can predict liver cirrhosis (F3 & F4) with an excellent degree of accuracy after HCV treatment. RDW/PLT cannot predict early liver fibrosis (F1 & F2) after HCV treatment as results assuming apoor degree of accuracy. According to above results RDW/PLT can be used instead of liver biopsy to detect degree of liver fibrosis and cirrhosis before HCV treatment with agood degree of accuracy. While after HCV treatment we can depend on RDW/PLT to predect degree of advanced liver fibrosis and cirrhosis (F3 & F4) with an excellent degree of accuracy. But we need further studies on RDW/PLT to detect the accuracy of prediction of early liver fibrosis (F1 & F2) after HCV treatment. RDW/PLT can predict liver fibrosis and cirrhosis with agood degree of accuracy before HCV treatment. RDW/PLT can predict liver cirrhosis (F3 & F4) with an excellent degree of accuracy after HCV treatment. RDW/PLT cannot predict early liver fibrosis (F1 & F2) after HCV treatment as results assuming apoor degree of accuracy. According to above results RDW/PLT can be used instead of liver biopsy to detect degree of liver fibrosis and cirrhosis before HCV treatment with agood degree of accuracy. While after HCV treatment we can depend on RDW/PLT to predect degree of advanced liver fibrosis and cirrhosis (F3 & F4) with an excellent degree of accuracy. But we need further studies on RDW/PLT to detect the accuracy of prediction of early liver fibrosis (F1 & F2) after HCV treatment.

Changes of Erythrocyte Electrophoresis Rate and Erythrocyte Membrane Cholesterol Concentration at Early Stage of Liver Cirrhosis in Rat

Predictive Value of the Red Blood Cell Distribution Width-to-platelet Ratio for Hepatic Fibrosis.

Dynamic Changes of Key Metabolites During Liver Fibrosis in Rats.

Quantitative Assessment of Ischemic Liver's Elastic Changes in Rabbits Using Acoustic Radiation Force Impulse (ARFI)

Alterations of Lipid Contents in Blood, Hepatocytes, and Enterocytes in the Early Stage of Acute Liver Failure Induced by 90% Hepatectomy in the Rat

Rising of Homocysteine Level in Plasma and Upregulating of Expression of PCNA in Rats with Liver Cirrhosis Induced by Carbon Tetrachloride

RDW, NLR and RLR in Predicting Liver Failure and Prognosis in Patients with Hepatitis E Virus Infection.

A serum metabonomic study on the difference between alcohol- and HBV-induced liver cirrhosis by ultraperformance liquid chromatography coupled to mass spectrometry plus quadrupole time-of-flight mass spectrometry.

The hepatocyte phase of Gd-EOB-DTPA-enhanced MRI in the evaluation of hepatic fibrosis and early liver cirrhosis in a rat model: An experimental study

Pathomorphological changes in the organs of laboratory animals with experimental liver cirrhosis

Changes of intrahepatic level of chemokine CCL25 and CX3CLl in rats with hepatic fibrosis

Functional Proteomic Analysis of Nonalcoholic Fatty Liver Disease in Rat Models: Enoyl-coenzyme a Hydratase Down-Regulation Exacerbates Hepatic Steatosis

Dynamic Observation Level of Endothelin in Plasma with Liverfibrosis

Changes of Blood Humoral Substances in Experimental Cirrhosis and Their Effects on Portal Hemodynamics.

SCANNING ELECTRON MICROSCOPE OBSERVATION ON CONSTRUCT OF THE COLLAGEN NETWORK IN CARBON TETRACHLORIDE INDUCED HEPATIC FIBROSIS RATS

Scanning Electron Microscopic Observation: Three-Dimensional Architecture of the Collagen in Hepatic Fibrosis Rats.

Evaluation of Red Cell Distribution Width (RDW) to Platelet Ratio as a Novel Non-Invasive Index for Predicting Hepatic Fibrosis in Patients with Chronic Hepatitis C before and after Antiviral Treatment

The Effect of Endothelial Progenitor Cell Transplantation on Liver Cirrhosis in Rats

Determination of plasma β-carotene in patients with liver cirrhosis and its significance

Non-Invasive Assessment of Liver Fibrosis in a Rat Model: Comparison of Shear Wave Elastography with Serologic Tests

Rdw To Platelet Ratio: A Novel Noninvasive Index For Predicting Hepatic Fibrosis And Cirrhosis In Chronic Hepatitis B